Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Chubb
Mallinckrodt
Johnson and Johnson
Moodys
Healthtrust
QuintilesIMS
UBS

Generated: December 15, 2018

DrugPatentWatch Database Preview

AXUMIN Drug Profile

« Back to Dashboard

Which patents cover Axumin, and what generic alternatives are available?

Axumin is a drug marketed by Blue Earth and is included in one NDA. There are three patents protecting this drug.

This drug has thirty-six patent family members in fifteen countries.

The generic ingredient in AXUMIN is fluciclovine f-18. One supplier is listed for this compound. Additional details are available on the fluciclovine f-18 profile page.

Summary for AXUMIN
International Patents:36
US Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 6
Clinical Trials: 4
Patent Applications: 16
DailyMed Link:AXUMIN at DailyMed
Drug patent expirations by year for AXUMIN
Generic Entry Opportunity Date for AXUMIN
Generic Entry Date for AXUMIN*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
NDA:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for AXUMIN
Synonyms for AXUMIN
(18F)FACBC
(18F)Fluciclovine
(18F)Ge-148
(1R,3R)-1-Amino-3(18f)fluorocyclobutane-1-carboxylic acid
[18F]-FACBC
[18F]FACBC
[18F]Fluciclovine
1-amino-3-fluoranylcyclobutane-1-carboxylic acid
18F fluciclovine
18F-Ge-148
222727-39-1
38R1Q0L1ZE
AC1L9P1E
AKOS030238192
anti-(18f)FABC
Anti-[18F]FACBC
anti-1-Amino-3-(18f)fluorocyclobutane-1-carboxylic acid
Anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic-acid
Anti-1-amino-3-F-18-fluorocyclobutane-1-carboxylic-acid
Anti-1-amino-3-fluorine-18-fluorocyclobutane-1-carboxylic acid
Anti-18-F-FACBC
Anti-18F-FABC
Anti-3-18F-FACBC
Anti-F-18-fluorocyclobutane-carboxylic-acid
AxuminCN FACBCCN Fluciclovine (18F)CN GE 148CN NMK 36
CHEBI:134703
CHEMBL254468
CHEMBL447701
D03QIP
D10860
DB13146
FACBC
FACBC F-18
Fluciclovine
Fluciclovine ((sup 18)F)
Fluciclovine ((sup 18)F) [INN]
Fluciclovine (18F)
Fluciclovine (18F) (INN)
Fluciclovine (18F) [INN]
Fluciclovine F 18
Fluciclovine F-18
Fluciclovine F18 [USAN]
Fluciclovine-F-18
GE-148
Ge-148 (18F)
Ge-148 F-18
Ge-148-18F
Ge-148-F-18
MOLI001120
NMK36
SCHEMBL10017245
SCHEMBL11939897
SCHEMBL11939900
syn-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
syn-3-[18F]FACBC
Trans-1-amino-3-18F-fluorocyclobutanecarboxylic-acid
UNII-38R1Q0L1ZE

US Patents and Regulatory Information for AXUMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Chubb
Mallinckrodt
Johnson and Johnson
Moodys
Healthtrust
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.